“…Importantly, in this research, we conceptualize BrainAGE as a marker of brain health with higher BrainAGE suggesting poorer brain health. This is because extensive research is available indicating that BrainAGE (and similar approaches)-in addition to being methodologically robust and reliable Gaser, 2012, 2019;Baecker et al, 2021)-is associated with cognitive decline, the transition from MCI to Alzheimer's disease, and markers of the underlying pathology and its main genetic risk factor, APOE genotype (Gaser et al, 2013;Löwe et al, 2016;Wang et al, 2019). Moreover, BrainAGE is significantly increased in several chronic conditions including type 2 diabetes (Franke et al, 2013), stroke (Egorova et al, 2019), Parkinson's disease (Beheshti et al, 2020), Multiple Sclerosis (Cole et al, 2020), and known health and lifestyle risk factors for cardiovascular health, neurodegeneration, brain ageing, and dementia (Bittner et al, 2021).…”